Genfit SA (GNFT)
3.79
-0.01
(-0.26%)
USD |
NASDAQ |
May 17, 16:00
3.79
0.00 (0.00%)
After-Hours: 20:00
Genfit Shares Outstanding: 49.86M for April 1, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 01, 2024 | 49.86M |
December 31, 2023 | 49.84M |
June 30, 2023 | 49.84M |
April 01, 2023 | 49.84M |
December 31, 2022 | 49.84M |
June 30, 2022 | 49.82M |
April 01, 2022 | 49.82M |
December 31, 2021 | 49.82M |
December 22, 2021 | 49.73M |
September 29, 2021 | 45.74M |
June 30, 2021 | 45.78M |
April 13, 2021 | 45.75M |
February 18, 2021 | 41.81M |
December 31, 2020 | 38.80M |
December 22, 2020 | 38.80M |
November 30, 2020 | 38.80M |
June 30, 2020 | 38.83M |
May 01, 2020 | 38.84M |
December 31, 2019 | 38.86M |
March 31, 2019 | 38.83M |
March 29, 2019 | 38.80M |
December 31, 2018 | 31.18M |
Date | Value |
---|---|
June 30, 2018 | 31.17M |
December 31, 2017 | 31.17M |
June 30, 2017 | 31.16M |
December 31, 2016 | 31.16M |
June 30, 2016 | 27.17M |
December 31, 2015 | 24.69M |
June 30, 2015 | 24.70M |
December 31, 2014 | 24.69M |
June 30, 2014 | 24.09M |
December 31, 2013 | 21.18M |
June 30, 2013 | 21.06M |
December 31, 2012 | 16.54M |
June 30, 2012 | 15.55M |
December 31, 2011 | 14.05M |
June 30, 2011 | 12.02M |
December 31, 2010 | 12.02M |
June 30, 2010 | 12.02M |
December 31, 2009 | 11.62M |
December 31, 2008 | 11.62M |
December 31, 2007 | 11.62M |
June 30, 2007 | 11.62M |
December 31, 2006 | 11.62M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
38.80M
Minimum
Dec 31 2020
49.86M
Maximum
Apr 01 2024
45.28M
Average
45.78M
Median
Jun 30 2021
Shares Outstanding Benchmarks
Biophytis SA | 0.2865M |
Cellectis SA | 71.95M |
Edap TMS SA | 37.10M |
DBV Technologies SA | 192.34M |
Adaptimmune Therapeutics PLC | 255.56M |